Evaluation of objective response, disease control and progression-free survival as surrogate end-points for overall survival in anti–programmed death-1 and anti–programmed death ligand 1 trials

作者：Run‐Cong Nie, Fo‐Ping Chen, Shuqiang Yuan, Ying-Shan Luo, Shi Chen, Yongming Chen, Xiao‐Jiang Chen, Ying-Bo Chen, Yuanfang Li, Zhiwei Zhou · 发表于：European Journal of Cancer · 年份：2018 · DOI：10.1016/j.ejca.2018.10.011 · 被引用次数：61 · 研究领域：Statistical Methods in Clinical Trials、Cancer Immunotherapy and Biomarkers、Lung Cancer Treatments and Mutations